Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1995-07-05
1997-09-02
Ivy, C. Warren
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514338, 5462767, 548430, A61K 3140, C07D491052
Patent
active
056631910
ABSTRACT:
Compounds of formula (I): ##STR1## in which: n represents 1 or 2,
REFERENCES:
patent: 4666916 (1987-05-01), Schneider
Forbes IT, Kennet GA, Gadre A, Ham P, Hayward CJ, Martin RT, Thompson M, Wood, MD, Baxter GS, Glen A, Murphy OE, Stewart BA, Blackburn TP. J. Med. Chem. 36, 1104-1107. 1993.
Wood MD, Glen A, Murphy O, Stewart BR, Blackburn TP. Brit. J. Pharmacol. 111, 144P. Jan. 1994.
Dubuffet Thierry
Lavielle Gilbert
Millan Mark
Newman-Tancredi Adrian
Adir et Compagnie
Huang Evelyn
Ivy C. Warren
LandOfFree
Benzopyran compounds as 5HT.sub.2C receptor antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Benzopyran compounds as 5HT.sub.2C receptor antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Benzopyran compounds as 5HT.sub.2C receptor antagonists will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-308593